David Heller net worth
Quick answer
David Heller's estimated net worth is $14.0M (range $9.8M – $21.0M) as of 2026. David Heller is Founder at C16 Biosciences. C16 Biosciences valuation.
David Heller is Founder at C16 Biosciences (YC S18). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: MIT
- Region: United States of America
- Industries: Healthcare, Industrial Bio
- Team size: 35
- Website: https://www.c16bio.com/
Who is David Heller?
David Heller is a founder of C16 Biosciences, which is focused on sustainable alternatives to palm oil. He participated in Y Combinator's Summer 2018 batch.
Highlights:
- MIT
- C16 Biosciences
- Y Combinator S18
Background
No public information is available regarding his ethnicity. Heritage/background labels may be inferred and are not verified identity documents.
About C16 Biosciences
C16 Biosciences is decarbonizing consumer products supply chains by producing next-generation ingredients. The company's biomanufacturing platform produces better performing, more sustainable alternatives to oils and fats, and their first product is an alternative to palm oil. The company owns and operates Palmless™ alternative fats and oils.
FAQ: David Heller net worth and C16 Biosciences valuation
What is David Heller's net worth?
David Heller's estimated net worth is $14.0M (range $9.8M – $21.0M) as of 2026. David Heller is Founder at C16 Biosciences. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is C16 Biosciences valuation?
C16 Biosciences's estimated valuation on Entrepreneurial Check is $200.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is David Heller's role?
David Heller is Founder at C16 Biosciences, a Y Combinator-backed startup (batch S18).